Stat | Value |
---|---|
Share Price (delayed ~1 day) | $0.066 |
Valuation - Range | $0.08 - $0.08 (from 1 Analysts) |
EPS | -$0.052 |
PE | 0 |
Dividend Yield | 0 |
Average Daily Volume | 230,606 shares / $15,220 |
Market Cap | $19.3m |
Shares on Issue | 292.2m |
Listing Date | 2016-08-09 |
Similar/Popular Websites | Biotechdispatch.com.au, Nextbiotech.com.au, Noxglobal.com, Noxmedical.com |
Common Search Phrases | Nox, Noxopharm, Nox66, Noxopharm In-licenses Novel Rna Technology For Drug Discovery And Vaccines, Nox Drug |
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences |
Stat | Value |
---|---|
Share Price (delayed ~1 day) | $0.475 |
Valuation - Range | $0.46 - $0.46 (from 4 Analysts) |
EPS | -$0.486 |
PE | 0 |
Dividend Yield | 0 |
Average Daily Volume | 466,636 shares / $221,652 |
Market Cap | $308.2m |
Shares on Issue | 662.8m |
Listing Date | 1991-04-18 |
Similar/Popular Websites | Iopt.com, Oceanpowertechnologies.com, Ophthotech.com, Optpluscard.com |
Common Search Phrases | Opthea, Opt, Opt-302, Megan Baldwin, Jeremy Levin |
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences |
Metric | Change |
---|---|
Share Price | $0.066 to $0.066 (+0.00%) |